PPAR-γ activation has a beneficial effect on improving AT function and glycemic control/insulin sensitivity, reducing production of inflammatory mediators/macrophage-specific genes and preventing progression of metabolic disorders [51]. This evidence concerns the gene PPARG and Other metabolic disease.